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Background

Severe sepsis is a major cause of mortality in patients evaluated in the Emergency Department (ED). Early initiation of antibiotic therapy and IV fluids in the ED is associated with
improved outcomes. We investigated whether early administration of antibiotics in the
prehospital setting improves outcomes in these patients with sepsis.
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(monica.melmer@gmail.
com)

Methods

This is a retrospective study comparing outcomes of patients meeting sepsis criteria in the
field by EMS, who were treated with IV fluids and antibiotics. Their outcomes were compared with controls where fluids were administered prehospital and antibiotics were initiated in the ED. We compared morbidity and mortality between these groups.

Results

Early antibiotics and fluids were demonstrated to show significant improvement in outcomes in the patients meeting sepsis criteria treated in the pre-hospital setting. The average age for sepsis patients receiving antibiotics in the prehospital setting was statistically
higher than that for patients in the historical control group, 73.23 years and 67.67, respectively (p < 0.036), and there was no statistically significant difference of Charlson Comorbidity
Index between the groups (p two-tail = 0.28). Average intensive care unit length of stay was
2.51 days in the in the prehospital group and 5.18 days in the historical controls, and the prehospital group received fewer blood products than the historical controls (p = 0.0003).

Conclusions

Early IV administration of antibiotics in the field significantly improves outcome in EMS
patients who meet sepsis criteria based on a modified qSOFA score.
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Introduction

Sepsis is a life-threatening condition that remains the leading cause of death in non-cardiac
intensive care units.1 Early prehospital recognition using sepsis identifying criteria and treatment of sepsis with intravenous broad-spectrum antibiotics and fluid resuscitation has
been thought to decrease overall mortality
in the septic patient.1, 2 Of note, prehospital

identification protocols have been shown to
effectively improve clinical outcomes in this
patient setting while improving workflow in
Emergency Departments (ED).2 The following
article depicts the benefits of prehospital care
more commonly addressed by EMS (Emergency Medical Service) protocols, activating a
sepsis alert in a timely manner as a means to
improve overall patient care delivery by reduc-
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ing in-hospital mortality. Studies have additionally demonstrated that EMS providers can
be successfully trained to obtain blood cultures
with low contamination rates comparable to
thresholds used in the inpatient setting.3 Previously developed prehospital sepsis screening
protocols have been limited by relatively low
sensitivity and/or specificity.4 A 2016 review of
prehospital management of sepsis by EMS providers found a lack of studies in the literature
exploring treatment and identification of sepsis
using objective, high quality criteria.5
The revision of sepsis with the Third International Consensus Definitions for Sepsis and
Septic Shock (Sepsis-3) is arguably the most
dramatic change in sepsis identification in the
past 25 years. The publication of Sepsis-3 cited
prior reliance on the systemic inflammatory
response syndrome (SIRS) criteria as inadequate in guiding clinical management, which
has sparked much debate.6, 7 Quick sequential
(sepsis-related) organ function assessment
(qSOFA) is another sepsis screening tool that
evaluates for the presence of two or more of
the following clinical criteria: altered mentation, respiratory rate ≥ 22 breaths per minute
and systolic blood pressure (SBP) ≤ 100 mmHg.
Proponents of qSOFA highlight that utilizing
clinical criteria readily available at the bedside
facilitates quicker identification of sepsis and
should replace all previous screening protocols.7 In the prehospital setting, qSOFA has the
benefit of using information that is immediately available to providers. SIRS, as a previously
utilized screening tool in EMS, is limited by
its inclusion of laboratory data, such as white
blood cell count and lactic acid levels, which are
typically not available before hospital arrival.
Therefore, qSOFA is a more feasible tool for
EMS providers in the field to perform using
their own clinical judgment.
There are multiple regulatory challenges in
advancing prehospital care. Variation in local
EMS protocols and guidelines is one of the
most encountered barriers.8, 9 The purpose
of this study is to evaluate the effect of early
EMS/prehospital recognition and treatment of
sepsis using modified qSOFA criteria on assessable items, such as hospital length of stay,
ICU stay, mechanical ventilator days, vasopressor utilization, blood product administration
and blood culture contamination. Obtaining
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blood cultures at an established rate or low
rate of contamination, beginning broad spectrum antibiotic therapy and initiating intravenous fluid treatment in the prehospital setting
with high-quality objective screening criteria
has the potential to decrease mortality.10 Previous studies have shown delay in ED antibiotic administration is associated with a 3–7%
increase in patient mortality for every 1 hour
delay in treatment.10 In this study, we hypothesized that prehospital antibiotics administered
in patients meeting sepsis criteria based on a
modified qSOFA score would improve morbidity and mortality in these patients.

Methods

Study Population and Setting

We conducted a retrospective study of patients transported to the ED at a busy academic medical center that sees approximately
100,000 patients per year. These patients met
sepsis criteria based on a modified qSOFA
score or in whom sepsis was clinically suspected prehospital. The modified qSOFA score
included hypo- or hyperthermia (temperature
< 95°F or > 100.4°F, respectively) in addition to
at least two of the following: altered mentation, respiratory rate ≥ 22 breaths per minute
and SBP ≤ 100 mmHg. Data were gathered
from the electronic health record (EHR) of
the participating hospital, as well as from the
patient care reports of participating EMS
agencies. Patients over the age of 18 years old
were included if they were transported by EMS
and if their modified qSOFA score was ≥ 2 with
hypo- or hyperthermia. Patients over the age
of 18 years old were excluded if they were not
transported by EMS or if EMS providers did
not suspect sepsis based on modified qSOFA
screening. Additionally, any patient who was
pregnant at the time of treatment was excluded from analysis, and patients with repeat enrollment only had their first occurrence included. EMS carried out these protocols between
October 2015 and April 2018.
The participating regional medical center assisted local EMS agencies in implementing a
sepsis protocol in two phases. Phase 1 included
standing orders for the use of intravenous fluid
(IVF) prehospital resuscitation with 1 liter of
normal saline and took place from October 2015
to September 2016. Phase 2 included standing
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Sepsis Patient Protocol
Contact, Droplet and Airborne Precautions
Oxygen
12-lead EKG
Obtain Blood Glucose Level (BGL)

BGL < 60
Evaluation for Sepsis:

Temperature < 95°F or > 100.4°F
2 or more of the following:
Change in mental status

Move to
appropriate
protocol

Respiratory rate ≥ 22 breaths per minute
SBP ≤ 100 mmHg

Draw 1 set of blood cultures
Draw lactic acid and put on ice
Initiate IV administration of 1000 mL of normal saline
Administer IV antibiotics
Establish second IV, when feasible
Notify destination/medical control of Sepsis Alert

Figure 1. Sepsis protocol for EMS administration of antibiotics. EKG = electrocardiogram; BGL =
blood glucose level; SBP = systolic blood pressure; IV = intravenous; EMS = emergency medicine
services
orders for the use of IVF resuscitation, as well
as administration of broad spectrum intravenous antibiotics according to suspected source
(ceftriaxone, cefepime or vancomycin). A blood
draw was obtained for the collection of venous
blood cultures and venous lactic acid to be
analyzed in the lab of the participating medical
center upon arrival to the ED (Figure 1). The
venous lactic acid blood draw was placed on ice
during transport. The first choice of antibiotic
for acute mental status change or urinary tract
infection was ceftriaxone 2 grams IV. The firstchoice of antibiotic for pneumonia, abdominal pain, diarrhea or suspected blood stream
or catheter related infection was cefepime 2
grams IV. The first-choice of antibiotic for skin,
soft tissue or wound infection was vancomycin
1 gram IV. Phase 2 was implemented starting October 2016 and continued to April 2018.
Sepsis patients transported by EMS during the
Phase 1 period served as a control for the study.

Data Collection

This study was approved by the Institutional
Review Board (IRB) of Edward Via College of
Osteopathic Medicine. Data were collected
on each patient group using the hospital EHR

and EMS patient care reports. Parameters of
interest were: length of hospital stay, length
of intensive care unit (ICU) stay, mortality,
number of days spent on a ventilator, number
of blood products used, whether vasopressors
were used, whether antibiotics were given prehospital, time from EMS arrival on scene to antibiotics, the type of antibiotic received, blood
culture collection and results, blood culture
contamination, venous lactate collection and
results, Charlson Comorbidity Index, qSOFA
score and discharge diagnosis. This study was
approved by the affiliated Institutional Review
Board.

Data Analysis

Once all data were compiled, comparisons were
made between the study cohort and control
group regarding patient in-hospital mortality
using a chi-square test with statistical significance set at p < 0.05. The hospital length of
stay, ICU length of stay, number of ventilator
days, number of blood products received, age
(with age greater than 90 years old adjusted
to 90 years for further de-identification) and
Charlson Comorbidity Index were compared
using T-tests for two samples assuming un-
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equal variance with statistical significance set
at p < 0.05. Chi-square tests were used to
determine whether a difference existed in the
use of vasopressors between the two groups,
as well as to examine whether there was a
difference in the use of mechanical ventilation
between the groups. A Fisher’s exact test was
used to determine if a difference existed in
rates of contamination of blood cultures between EMS providers and nursing staff of the
ED of the participating hospital. Additionally,
patients’ final diagnoses (sepsis, severe sepsis, septic shock or other diagnosis), alongside
their respective qSOFA scores for the study
cohort, were observed to determine the rate
at which sepsis was detected. It is noteworthy that the participating hospital used SIRS
criteria for diagnosis of sepsis rather than the
modified qSOFA screening performed by EMS.
Therefore, the charts for patients whose final
diagnoses did not include sepsis, severe sepsis
or septic shock were reviewed to determine if
they should have been assigned such a diagnosis based on these criteria. We conducted additional review of a subset of the data limiting
inclusion to only subjects of the study cohort
with qSOFA ≥ 2.

Results

Protocol Compliance

There were 345 total participants, with 47
included in the study cohort and 298 in the
historical control. Of the 47 patient encounters included in the study cohort, 43 (91%)
received prehospital IV antibiotics. Of those 47
patients, 51% received ceftriaxone, 32% received cefepime and 9% received vancomycin.
The remaining 9% did not receive prehospital
antibiotics. Average time to antibiotics for the
study cohort (regardless of whether antibiotics
were received prehospital) was 31.4 minutes
(standard deviation = 19.51). The median qSOFA score for those patients receiving antibiotic
therapy prehospital was 2, and the median
qSOFA score for those 4 patients not receiving

antibiotic therapy prehospital was also 2.
Ninety-three percent of patients receiving
prehospital antibiotics also received IVF resuscitation with normal saline. Ninety percent of
patients receiving both IV antibiotics and IVF
prehospital also had blood cultures and a lactic
acid sample drawn by EMS. Of the 4 patients
who did not receive prehospital antibiotics,
75% received IVF. None of these 4 patients had
blood cultures or lactic acid samples drawn.
There were three documented cases of unsuccessful attempts at IV access, which precluded
EMS from administering IVF, antibiotics and
from obtaining blood samples. There was a
single instance of intraosseous (IO) catheterization rather than IV catheterization, and the
IO access was not used for lab draws.

Demographics

The median age for the control group was 68
years, and there were 158 males and 140 females. The cohort group from the Phase 2 period October 2016 to April 2018 consisted of 25
males and 22 females with a median age of 77.5
years. The patients in the cohort group were
transported by a single EMS agency, and the
patients in the control group were transported
by multiple EMS agencies (Table 1). A T-test
showed a statistically significant difference in
the ages (p = 0.04) between the groups with
a higher average for the patients in the study
cohort versus the control. A comparison of the
average Charlson Comorbidity Index, which
predicts 10-year survival by taking into account
patient comorbidities, was performed between
the two groups. This demonstrated 4.64 (95%
CI, 3.96–5.32) for the study cohort and 4.24
(95% CI, 3.95–4.50) for the control, revealing
no statistically significant difference by T-test
analysis (p two-tail = 0.26).

Mortality

A difference was found between the two
groups’ in-hospital mortality rates. Four pa-

Table 1. Patient Demographics by Group Including Age, Sex and Charlson Comorbidity Index

Age (years), median
Males (%)
Charlson Comorbidity Index
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Study cohort (n=47)

Historical control (n=298)

77.5

68

25 (53.2%)

158 (53%)

4.64 (95% CI, 3.96–5.32)

4.24 (95% CI, 3.95–4.50)
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In-Hospital Mortality Comparison Between Study Cohort and Control

Number of Subjects

350
300

25.50%

250
200
150
100

8.51%

50
0

Control

Study cohort

Group
Alive

Expired

Figure 2. Comparison of in-hospital mortality between the study cohort (n=47) and historical controls (n=298). We found a reduction in mortality among the study cohort (n=4) compared to the
historical control (n=76), (χ2 = 6.582; p = 0.01).
tients (8.5%) from the study cohort expired,
while 76 (25.5%) patients from the control
group expired. This lower mortality in the
study cohort was statistically significant (χ2
= 6.582; p = .01) and represented an approximately 66% decrease in in-hospital mortality
between the groups (Figure 2).

Hospital Length of Stay

The study cohort had a mean hospital length
of stay of 11.85 days (95% CI, 6.47–17.23), and
the control group had a mean hospital length
of stay of 10.62 days (95% CI, 9.12– 2.12). The
two-sample T-test showed there was no significant difference between these two groups’
lengths of hospital stay (p two-tail = 0.66).

ICU Length of Stay

Patients in the study cohort stayed an average
of 2.51 days (95% CI, 0.28–4.74) in the ICU; patients from the control group spent an average
of 5.18 days (95% CI, 4.31–6.06) in ICU care.
The two-sample T-test showed a statistically
significant difference in these two means (p
two-tail = 0.03).

Ventilator Days

Patients of the study cohort averaged 1.91 days
(95% CI, -0.22 – 4.04) on a mechanical ventilator, and patients of the control group spent an
average of 2.48 days (95% CI, 1.74–3.22) on a
mechanical ventilator. The two-sample T-test
showed no statistically significant difference
between these two means between the groups
(p = 0.62). The chi-square test to determine
whether a difference existed in the use of

mechanical ventilation between the two groups
revealed no significant difference (χ2 = 2.0369;
p = 0.15).

Blood Products

In the study cohort, patients received an average of 0.28 blood products (95% CI, 0.02–0.54)
while in the hospital; whereas patients from
the control group received an average of 1.10
blood products (95% CI, 0.74–1.46) during their
stay. A two-sample T-test showed that there
was a statistically significant difference between the mean number of blood products received between the groups (p two-tail < 0.001).

Blood Culture Contamination

In the study cohort, EMS providers collected a
total of 41 blood cultures with 1 blood culture
per patient. Of these, 30 were negative (no
growth), and 11 were positive (growth detected
after 3 days). Of the 11 positive blood cultures,
four were flagged in the EHR as possible
instances of contamination. This constitutes
a contamination rate of 9.8% of total blood cultures drawn by EMS. Nursing staff in the ED
collected a total of 53 blood cultures, including
45 negative cultures and 8 positive cultures. Of
these 8 positive cultures, only one was identified as a possible instance of contamination.
This resulted in a contamination rate of 1.9% of
total blood cultures drawn from these patients.
A Fisher’s exact test revealed that the difference in rates of contamination between these
two groups was not statistically significant
(Fisher’s exact p = 0.16). The sepsis coordinator
for the participating hospital—with infectious
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disease input—reviewed cases in which the
lab technicians recognized blood cultures as
possible or probable contaminants and believed
none of these were instances of true contamination.

Vasopressors

The chi-square test to determine whether a
difference existed between the two groups
regarding the prevalence of vasopressor use in
patient resuscitation showed no statistically
significant difference (χ2 = 2.961; p = 0.09).

Modified qSOFA Prediction of Sepsis

In all, 40 patients of 47 from the study cohort
had a final diagnosis of sepsis, severe sepsis or
septic shock. Of these patients, 35 (89%) were
assigned a qSOFA score ≥ 2 and were hypo- or
hyperthermic. Additionally, 6 patients were
assigned a qSOFA score ≥ 2 and were hypo- or
hyperthermic but did not have a final diagnosis
of sepsis, severe sepsis or septic shock.

Subset Analysis for qSOFA ≥ 2

The subset of study cohort patients with
qSOFA ≥ 2 comprised 41 patients, of whom
35 were assigned a diagnosis of sepsis. Four
patients (10%) in this subset expired. Chisquare analysis revealed that this mortality rate
was significantly lower than mortality in the
control group (χ2 = 6.0346, p = 0.01). Within
this subset of the study cohort, average hospital length of stay was 12.85 days (95% CI,
6.74–18.96) compared to 10.62 days (95% CI,
9.12–12.12, p two tail = 0.48). Mean ICU length
of stay for the study cohort of 2.51 days (95%
CI, 0–5.02) was shorter than the control group
mean of 5.18 days (95% CI, 4.31–6.06, p two tail
= 0.048). The study cohort subset averaged
1.98 ventilator days (95% CI, -0.44–4.39), which
was not statistically different from the control
average of 2.48 days (95% CI, 1.74–3.22, p two
tail = 0.69). There was no difference in use of
mechanical ventilation between the groups on
chi-square analysis (χ2 = 1.4778; p = 0.22). The
patients of this subset required an average of
0.32 blood products (95% CI, 0.02–0.61), which
was statistically fewer than the control requirement of 1.10 blood products (95% CI, 0.74–1.46,
p two tail < 0.001). There was no statistically
significant difference in vasopressor use between this subset of the study cohort and the
control when analyzed by chi-square test (χ2 =
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2.3447; p = 0.13). Additionally, the average patient age for the study cohort subset was 73.63
years (95% CI, 68.71–78.56), which was statistically greater than the cohort average age of
67.71 years (95% CI, 66.05–69.29, p two tail =
0.02). The average Charlson Comorbidity Index
for the subset was 4.61 (95% CI, 3.88–5.34),
and it was not statistically different from the
control average of 4.22 (95% CI, 3.95–4.50, p
two tail = 0.33).

Discussion

The present study demonstrates that when
EMS providers initiate sepsis alert protocols
including IVF, IV antibiotics and blood collection
for patients with suspected sepsis it significantly reduces mortality when compared to
suspected sepsis patients transported under
protocols allowing for IVF resuscitation only.
Previous studies have highlighted the importance of not delaying goal-directed therapy
in sepsis patients.1, 2 Though other research
studies have addressed the subject of prehospital identification of sepsis and/or prehospital
treatment through IVF resuscitation.3, 4, 5 we
believe that this is the first study to explore
the impact of prehospital sepsis protocols that
include IVF, IV antibiotics and blood collection
on in-hospital mortality for sepsis patients
identified using the modified qSOFA screening
criteria by EMS personnel.
A study of all non-trauma, non-arrest EMS
encounters from 2000 to 2009 transported to
a hospital by King County EMS (King County,
Washington) showed that 3.3 per 100 EMS
encounters were patients with severe sepsis,
which represent a higher rate of EMS encounters for acute myocardial infarction or stroke.11
Other studies suggest that over half of sepsis
patients seen in the ED utilize EMS for transport.12, 13 Early recognition and treatment of
sepsis in the prehospital scene may produce
a positive impact in the care and outcome of
these patients. Guerra et al. conducted a study
on the implementation of a sepsis alert protocol for EMS providers where the receiving
hospital was notified of incoming severe sepsis
patients. It was found that these trained EMS
providers identified fewer than half (47.8%) of
severe sepsis patients they transported, and
the mortality of the group in whom severe sepsis was recognized was much lower than those
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Figure 3. Average hospital and ICU length of stay for study cohort versus historical controls. The
study group had a significantly shorter ICU length of stay (2.51 days [95% CI, 0.28 – 4.74] vs 5.18
days [95% CI, 4.31 – 6.06]), two-sample t-test p = 0.03*.
in whom sepsis was not recognized.14 A prospective study of EMS sepsis patients revealed
that treatment by EMS with IVF resuscitation
was associated with reduced hospital mortality
when compared to prehospital treatment with
intravenous catheter alone.15 Furthermore,
recognition of sepsis in the prehospital setting
has been associated with reduced time to antibiotics administered in the ED for severe sepsis
patients.16, 17, 18 while delays in antibiotic administration have been associated with increased
in-hospital mortality.19

Though the Fisher’s exact test comparing
nursing and EMS rates of blood culture contamination did not achieve statistical significance (Figure 4), the observed rate of nearly
10% contamination by EMS providers is higher
than previously reported in the literature.3 The
potential for contamination in the prehospital
environment may be higher than in the hospital. This result represents an opportunity for
better training in aseptic phlebotomy technique
for those EMS providers who will be drawing
blood cultures in the field.

There is a paucity of literature relating prehospital treatment of sepsis and length of hospital
or ICU stay. Though Femling et al. reported a
shorter time to antibiotic therapy and central
line placement for severe sepsis patients, they
found no improvement in hospital length of
stay. However, they did show that severe sepsis
patients receiving high-volume IVF resuscitation experienced shorter hospital stays than
those who did not.17 In one of the few published reports to examine the use of prehospital
IV antibiotic therapy for septic shock, Chamberlain demonstrated a reduction in mean
ICU length of stay for septic shock patients
receiving prehospital antibiotics versus those
who received their first antibiotics in the ED.20
Our results further demonstrate that patients
transported by EMS under protocols allowing
prehospital IV antibiotic therapy do not experience shorter overall hospital lengths of stay.
Yet they do experience shorter ICU lengths of
stay compared to patients transported by EMS
prior to the establishment of prehospital antibiotic protocols for sepsis (Figure 3).

When subset analysis was conducted for study
cohort subjects with qSOFA ≥ 2 only, all results
mirrored those of the study cohort (including
patients with qSOFA < 2). We still observed
lower morbidity, mortality, reduced use of
blood products and decreased length of ICU
stay for these patients versus the historical
control. There were no differences between
this subset of the study cohort and the control
with regards to overall hospital length of stay,
average ventilator days or use of vasopressors.

Limitations

In addition to the limitations inherent to a
retrospective study, the primary limitations
for this study lie in population selection. Some
patients were included with qSOFA < 2 into the
study cohort after thorough chart review of the
admitting and discharge diagnoses, as well as
the clinical course by the hospital sepsis coordinator. The study cohort was a relatively small
sample of 47 patients transported by a single
EMS agency. A larger sample of patients may
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Blood Culture Contamination Rates by Provider

Number of blood cultures

60
50

1.89%
9.76%

40
30
20
10
0

EMS
Number blood cultures drawn

Nursing
Number blood cultures contaminated

Figure 4. Blood culture contamination rates by emergency medical services (EMS) and nursing providers for the study cohort. The number of contaminated blood cultures was derived by
hospital lab technicians’ charting of possible contamination. There was no statistical difference
between the rates of contamination (Fisher’s exact test, p = 0.16).
have resulted in a higher level of precision for
the measured parameters; however, the data
obtained in this initial study remains promising.
The number of negative blood cultures obtained reflect the difficulty in diagnosing early
sepsis, even with established parameters, such
as qSOFA criteria. Obtaining blood cultures in
the prehospital setting is worthwhile, as it may
direct antibiotic selection in admitted patients,
in addition to complying with the Surviving
Sepsis Guidelines. Initial antibiotic selection
in the prehospital setting was driven by suspected source using local EMS protocol. Upon
hospital arrival further antibiotic selection was
completed by the admitting physician. Meanwhile, the control group included 298 patients
transported by multiple EMS agencies under
a protocol allowing for IVF resuscitation for
suspected sepsis but not IV antibiotics. There
could be a difference in population demographics that confound the results, given the wider
inclusion of patients for the Phase 1 group.
T-test analysis of the ages for the study cohort
and the control group showed a statistically
significant difference with a higher average age
for the study cohort. T-test of the Charlson
Comorbidity Index for both groups revealed no
significant difference. If the observed differences in mortality and ICU length of stay are
not due to the implementation of protocols
for prehospital antibiotic administration, then
it may be the case that EMS providers have
become more adept at recognizing sepsis in
the prehospital setting. Additionally use of
the Charlson Comorbidity Index to determine
illness severity might contribute to selection
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bias, although there is no statistical difference
between the groups. Average time to antibiotics was not analyzed in the control group due
to limitations of data de-identification. Future
studies may benefit from these additional
points of comparison. Finally, over the past
several years we have as a healthcare system
put more emphasis on sepsis bundle compliance. Our study may have benefited from the
overall improvements in hospital care that have
taken place during this time.

Conclusion

The present study is the first to find an association between prehospital antibiotics and
in-hospital morbidity and mortality for sepsis patients identified by using the modified
qSOFA. In this study, we demonstrated that
prehospital administration of IV antibiotics
by EMS personnel for patients suspected of
having sepsis improved ICU length of stay and
lowered mortality in comparison to historical
controls. The same results were found when
only patients with qSOFA ≥ 2 were taken into
account. These results suggest that patients
with suspected sepsis should be treated with
IV antibiotics in the prehospital setting.
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